Skip to content

Clinical trials

Phase 2 Pulmonary Disease, Chronic Obstructive trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 2 Country / region: Sweden Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20083
20091
20104
20112
20124
20131
20141
20171
20181
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline7
AstraZeneca6
Pfizer2
Aquinox Pharmaceuticals (Canada) Inc.1
Boehringer Ingelheim1
Genentech, Inc.1
Mereo BioPharma1
Novartis Pharmaceuticals1
PharmaLundensis AB1
Region Skane1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive23
Lung Diseases2
Respiratory Aspiration2
Emphysema1
Respiration Disorders1
alpha 1-Antitrypsin Deficiency1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.